THERAPEUTIC DRUG FOR DISEASES RELATED TO ENDOPLASMIC RETICULUM CELL DEATH IN CORNEAL ENDOTHELIUM

• 收藏
• 分享

专利权人:

Kyoto Prefectural Public University Corporation

发明人:

KOIZUMI, Noriko,OKUMURA, Naoki,KINOSHITA, Shigeru

申请号：

EP14857909

公开号：

EP3064222A4

申请日:

2014.10.30

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention provides a treatment drug or prophylactic drug for diseases, disorders, or conditions related to endoplasmic reticulum (ER) stress. Specifically, the present invention provides a treatment drug or prophylactic drug for diseases, disorders, or conditions related to endoplasmic reticulum (ER) stress in the corneal epithelium, the drug containing a TGF²-signal inhibitor. As a preferred TGF²-signal inhibitor, the drug contains 4-[4-(1,3-benzodioxole-5-yl)-5-(2-pyridinyl)-1H-imidazole-2-yl]benzamide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/